Searched for
PHARMACEUTICAL STOCKS
Laurus Labs shares tumble nearly 9% after promoters sell stake worth Rs 500 crore; multibagger stock up 122% in one yearLaurus Labs shares fell nearly 9% after promoters, including founder and CEO Satyanarayana Chava, sold over 20 lakh shares worth Rs 487 cro...
FPIs pump Rs 84,290 crore into D-Street in first fortnight of NovemberForeign Portfolio Investors made substantial investments in Indian equities during the first half of November. This influx followed two mon...
JioBlackRock Flexi Cap Fund exits ITC, BSE, MCX, TCS and 17 more, trim exposure in HDFC Bank, Adani Energy and 16 othersJioBlackRock Flexi Cap Fund made notable exits from various stocks including ITC and Tata Consultancy Services. The fund also reduced its e...
These large-, mid- and small-cap stocks have upside potential of more than 20% in 1 year, according to analystsThe probability of a sharp, damaging downturn now appears low, and the broad direction favours the market. So, the stance should be the sam...
Alice Huang was introduced to Nvidia's former CEO Jensen Huang, allegedly by her husband, Kang Wei. Who is he?Jensen Huang, the disgraced founder of Nvidia, has recently made headlines for having two extramarital affairs: with Kimberley Powell, the ...
What are retail investors buying? The bets just got bigger in 50 multibaggers that soared up to 1,400%Retail investors are actively bolstering their positions in various stocks that have delivered exceptional returns this year. Companies suc...
Good days for markets ahead? Here's what Nithin Kamath says on Q2 earnings recoveryZerodha co-founder Nithin Kamath sees improving corporate earnings supporting India's equity recovery. September-quarter results showed str...
USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (...
Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
Hidden pain! Why did investors lose money in 750 smallcaps when Nifty rallied 2500 points?The Nifty has rallied nearly 13% in a month, but the recovery has bypassed hundreds of smaller stocks. ACE Equity data shows 769 stocks dec...
Gland Pharma shares jump 4% after Q2 profit jumps 58%, revenue rises 23% YoYGland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. Th...
AMFI reshuffle: Jio Platforms and NSE may get largecap status, Vedanta may become midcap in H1 CY27Nuvama expects Jio Platforms and NSE to enter AMFI's largecap category in its H1 CY27 reshuffle, while Vedanta may move to midcap status. T...
South Korean shares rebound as chipmakers recover from AI-driven selloffSouth Korean shares rebounded on Monday as benchmark index KOSPI rose over 1.5%. Chip giants Samsung Electronics and SK Hynix led the recov...
PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horsesHDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 20...
Diwali shagun ke shares! Angel One selects 8 stocks with up to 50% upside to Buy this Diwali. How many do you own?Angel One identifies seven stocks across banking, finance, pharmaceuticals, jewellery, engineering and defence, highlighting their earnings...
These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
Sai Life Sciences shares rally 9% after Q2 results; net profit rises 17%, revenue up 23%Sai Life Sciences shares jumped nearly 9% to a fresh 52-week high after strong second-quarter results. Revenue rose 23%, while net profit i...
Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 crGlenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from...
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
Bayer raises 2026 profit outlook on strong pharmaceuticals performanceBayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German gr...